Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

N-Acetyltransferase 2 Genotype-Dependent N-Acetylation of Hydralazine in Human Hepatocytes

Cecily E. Allen, Mark A. Doll and David W. Hein
Drug Metabolism and Disposition December 2017, 45 (12) 1276-1281; DOI: https://doi.org/10.1124/dmd.117.078543
Cecily E. Allen
Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark A. Doll
Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David W. Hein
Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David W. Hein
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 45 no. 12 1276-1281
DOI 
https://doi.org/10.1124/dmd.117.078543
PubMed 
29018032

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received September 8, 2017
  • Accepted October 6, 2017
  • Published online November 3, 2017.

Article Versions

  • Earlier version (October 10, 2017 - 06:21).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Cecily E. Allen,
  2. Mark A. Doll, and
  3. David W. Hein
  1. Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky
  1. Address correspondence to:
    David W. Hein, Kosair Charities CTR-Room 303, 505 South Hancock St., Louisville, KY 40202. E-mail: d.hein{at}louisville.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2017 to January 2021

AbstractFullPdf
Oct 20174911190
Nov 20173334763
Dec 20171311916
Jan 2018671113
Feb 201858312
Mar 201832415
Apr 2018511110
May 20183952
Jun 20182025
Jul 201825511
Aug 20183248
Sep 20182425
Oct 20181914
Nov 20185267
Dec 20187189
Jan 201922314
Feb 201941822
Mar 201921512
Apr 201922412
May 201942113
Jun 201951913
Jul 201932411
Aug 201934116
Sep 20193235
Oct 201972116
Nov 20198319
Dec 2019105010
Jan 20207313
Feb 202034611
Mar 202034616
Apr 202002813
May 202002732
Jun 202033012
Jul 20201236
Aug 202012816
Sep 202062415
Oct 202023312
Nov 202031413
Dec 20207188
Jan 202131326

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 45 (12)
Drug Metabolism and Disposition
Vol. 45, Issue 12
1 Dec 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
N-Acetyltransferase 2 Genotype-Dependent N-Acetylation of Hydralazine in Human Hepatocytes
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Genotype-Dependent Hydralazine N-Acetylation in Hepatocytes

Cecily E. Allen, Mark A. Doll and David W. Hein
Drug Metabolism and Disposition December 1, 2017, 45 (12) 1276-1281; DOI: https://doi.org/10.1124/dmd.117.078543

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Genotype-Dependent Hydralazine N-Acetylation in Hepatocytes

Cecily E. Allen, Mark A. Doll and David W. Hein
Drug Metabolism and Disposition December 1, 2017, 45 (12) 1276-1281; DOI: https://doi.org/10.1124/dmd.117.078543
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
  • Gene expression profile of human intestinal epithelial cells
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics